122 related articles for article (PubMed ID: 11893655)
41. MUC5B: a good target for future therapy in pulmonary fibrosis?
Mahida R; Turner AM
Thorax; 2013 May; 68(5):401. PubMed ID: 23329274
[No Abstract] [Full Text] [Related]
42. Thymic disorders and myasthenia gravis: genetic aspects.
Zelano G; Settesoldi D; Lino MM; Batocchi A; Evoli A; Tonali PA
Ann Med; 1999 Oct; 31 Suppl 2():46-51. PubMed ID: 10574155
[TBL] [Abstract][Full Text] [Related]
43. [Implication of genetic polymorphisms for kidney transplant outcome].
Sato S; Miura M; Saito M; Numakura K; Tsuchiya N; Inoue K; Kagaya H; Suzuki T; Habuchi T
Nihon Jinzo Gakkai Shi; 2008; 50(7):864-8. PubMed ID: 19069141
[No Abstract] [Full Text] [Related]
44. Editorial: molecular insights into systemic sclerosis-associated interstitial lung disease.
Silver RM; Feghali-Bostwick CA
Arthritis Rheumatol; 2014 Mar; 66(3):485-7. PubMed ID: 24574206
[No Abstract] [Full Text] [Related]
45. [Sarcoidosis and genetics].
Pacheco Y
Rev Mal Respir; 2011 Apr; 28(4):409-18. PubMed ID: 21549897
[TBL] [Abstract][Full Text] [Related]
46. The genetic and environmental causes of pulmonary fibrosis.
Macneal K; Schwartz DA
Proc Am Thorac Soc; 2012 Jul; 9(3):120-5. PubMed ID: 22802285
[TBL] [Abstract][Full Text] [Related]
47. Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction.
Pechkovsky DV; Prasse A; Kollert F; Engel KM; Dentler J; Luttmann W; Friedrich K; Müller-Quernheim J; Zissel G
Clin Immunol; 2010 Oct; 137(1):89-101. PubMed ID: 20674506
[TBL] [Abstract][Full Text] [Related]
48. Environmental triggers and susceptibility factors in idiopathic granulomatous diseases.
Spagnolo P; Richeldi L; du Bois RM
Semin Respir Crit Care Med; 2008 Dec; 29(6):610-9. PubMed ID: 19221959
[TBL] [Abstract][Full Text] [Related]
49. Genetics of scleroderma.
Black CM; Welsh KI
Clin Dermatol; 1994; 12(3):337-47. PubMed ID: 7954192
[No Abstract] [Full Text] [Related]
50. [Influence of alleles and haplotypes of the main histocompatibility complex on the susceptibility to systemic lupus erythematosus in the Mexican population].
Granados J; Zúñiga J; Acuña-Alonzo V; Rosetti F; Vargas-Alarcón G
Gac Med Mex; 2006; 142(3):195-9. PubMed ID: 16875346
[TBL] [Abstract][Full Text] [Related]
51. Diffuse lung disease: product of genetic susceptibility and environmental encounters.
Lympany PA; du Bois RM
Thorax; 1997 Jan; 52(1):92-4. PubMed ID: 9039244
[TBL] [Abstract][Full Text] [Related]
52. Transforming growth factor beta1 gene polymorphism in patients with systemic sclerosis.
Sugiura Y; Banno S; Matsumoto Y; Niimi T; Yoshinouchi T; Hayami Y; Naniwa T; Ueda R
J Rheumatol; 2003 Jul; 30(7):1520-3. PubMed ID: 12858451
[TBL] [Abstract][Full Text] [Related]
53. [Idiopathic interstitial pneumonia and TNF gene restriction fragment length polymorphism].
Ohe M; Munakata M; Kawakami Y
Nihon Rinsho; 1996 Feb; 54(2):544-9. PubMed ID: 8838112
[TBL] [Abstract][Full Text] [Related]
54. Chemokine gene expression and clonal analysis of B cells in tissues involved by lymphoid interstitial pneumonitis from HIV-infected pediatric patients.
Teruya-Feldstein J; Kingma DW; Weiss A; Sorbara L; Burd PR; Raffeld M; Mueller BU; Tosato G; Jaffe ES
Mod Pathol; 2001 Oct; 14(10):929-36. PubMed ID: 11598160
[TBL] [Abstract][Full Text] [Related]
55. European Respiratory Society statement on familial pulmonary fibrosis.
Borie R; Kannengiesser C; Antoniou K; Bonella F; Crestani B; Fabre A; Froidure A; Galvin L; Griese M; Grutters JC; Molina-Molina M; Poletti V; Prasse A; Renzoni E; van der Smagt J; van Moorsel CHM
Eur Respir J; 2023 Mar; 61(3):. PubMed ID: 36549714
[TBL] [Abstract][Full Text] [Related]
56. The functional polymorphisms of NRAMP1 gene in Greeks with sarcoidosis.
Gazouli M; Koundourakis A; Ikonomopoulos J; Gialafos EJ; Papaconstantinou I; Nasioulas G; Lukas JC; Gorgoulis VG
Sarcoidosis Vasc Diffuse Lung Dis; 2007 Sep; 24(2):153-4. PubMed ID: 18496987
[No Abstract] [Full Text] [Related]
57. Management of suspected monogenic lung fibrosis in a specialised centre.
Borie R; Kannengiesser C; Sicre de Fontbrune F; Gouya L; Nathan N; Crestani B
Eur Respir Rev; 2017 Jun; 26(144):. PubMed ID: 28446600
[TBL] [Abstract][Full Text] [Related]
58. Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients.
Lucas SEM; Raspin K; Mackintosh J; Glaspole I; Reynolds PN; Chia C; Grainge C; Kendall P; Troy L; Schwartz DA; Wood-Baker R; Walsh SLF; Moodley Y; Robertson J; Macansh S; Walters EH; Chambers D; Corte TJ; Dickinson JL
Pulmonology; 2023; 29(3):257-260. PubMed ID: 36216738
[No Abstract] [Full Text] [Related]
59. Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease.
Mackintosh JA; Chambers DC
Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 38237995
[No Abstract] [Full Text] [Related]
60. Genetic analysis of sporadic and familial interstitial pneumonia.
Schwartz DA
Proc Am Thorac Soc; 2008 Apr; 5(3):343-7. PubMed ID: 18403331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
